Who
David J. Croyle
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Callan JMB.
In numbers
- Trades disclosed
- 6
- Buys
- 4
- Sells
- 0
- Bought
- $298K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Feb 2025
- Last trade
- 20 Mar 2026
- Last filed
- 26 Mar 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Mar 2026filed 26 Mar 2026 | CJMB Callan JMBBusiness Services | SEC FORM 4 Bought | $18K10,195 at $1.75 | filing |
| 20 Mar 2026filed 26 Mar 2026 | CJMB Callan JMBBusiness Services | SEC FORM 4 Bought | $18K10,195 at $1.75 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CJMB Callan JMBBusiness Services | SEC FORM 4 Bought | $26K14,805 at $1.76 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CJMB Callan JMBBusiness Services | SEC FORM 4 Bought | $26K14,805 at $1.76 | filing |
| 27 Mar 2025filed 3 Apr 2025 | CJMB Callan JMBBusiness Services | SEC FORM 4 Bought | $113K25,000 at $4.50 | filing |
| 5 Feb 2025filed 14 Mar 2025 | CJMB Callan JMBBusiness Services | SEC FORM 4 Bought | $98K24,375 at $4.00 | filing |
News
Callan JMB Inc.: Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and AssemblyCJMB · finanznachrichten.de · 8 Oct 2026
0 headlines in the last 90 days name David J. Croyle; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.